Guardant Health(us:GH)

42.02

-3.38%

Updated on 2025-04-03

Open:41.00
Close:42.02
High:42.44
Low:40.22
Prev Close:43.49
Volume:1.38M
Turnover:57.61M
Turnover Ratio:1.12%
Shares:123.42M
MarketCap:5.19B
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-3031311658817394.81%6783126
2024-03-3132011227072692.19%4183158
2023-12-3133711248180392.48%5178164
2023-09-3033710930664992.75%48100135
2023-06-3034311030633093.75%75100127
2023-03-313229034653387.96%42107133
2022-12-313729205870689.71%5790187
2022-09-303689268332490.50%50116146
dateorgNametotalratiochangeShareschangeRatio
2024-06-30Vanguard Group Inc116367329.46%2007061.75%
2024-06-30Blackrock Inc.112378569.14%2239242.03%
2024-06-30Baillie Gifford & Co60932864.96%-138818-2.23%
2024-06-30Deep Track Capital, Lp45000003.66%-1500000-25.00%
2024-06-30Capital International Investors44687233.63%64578416.89%
2024-06-30Eventide Asset Management, Llc37605383.06%-418894-10.02%
2024-06-30Temasek Holdings (Private) Ltd37491023.05%-362070-8.81%
2024-06-30Wellington Management Group Llp35087432.85%3508743
2024-06-30Citadel Advisors Llc32908972.68%50035917.93%
2024-06-30Ubs Asset Management Americas Llc32330442.63%2331011258.42%

About

Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.
Address:3100 Hanover Street

Market Movers